30 January 2015

Sinclair IS Pharma cuts loss 

22/09/2011 Robert Tyerman

Recently-merged Sinclair IS Pharma (SPH.L) has cut annual losses 31 per cent to £11.7 million and launched an Asia-Pacific marketing drive. The AIM-quoted company, which specialises in oral health, dermatology and wound care, increased turnover 19 per cent to nearly £33 million in the year to June.

Steered by entrepreneurial chief executive Chris Spooner, Sinclair, whose losses before exceptional items rose 14.5 per cent to £5.8 million, achieved several product launches last year. The company introduced its Autopiclair eczema and dermatitis cream into France, a market which returned to growth last year with a 21 per cent turnover gain to £12.5 million, and took its Kelo-cote scar reduction formulation into several European markets.

Outgoing chairman John Gregory says the merger of Sinclair Pharma with IS Pharma should lead to annual cost savings of £1 million and has already started to pay off more positively, as with a marketing agreement for the company's Episil treatment for oral mucositis pain. Grahame Cook, already a Sinclair director, will now chair the company, which has already launched two dermatology products in seven Asia-Pacific countries under its partnership with Singapore-based Invida Holdings, a leader in commercialising bio-pharmaceutical and healthcare products in the region.

Sinclair, which ended the financial year with £5 million cash, now has a 'bio-film busting' mouthwash for sale in the USA under the PerioShield banner through an agreement with Sunstar Americas and has several new products in the pipeline. Highlighted by Growth Company Investor at 28p last autumn, Sinclair shares have eased to 24p, valuing the company at £93.3 million, but could still outperform some sector peers over the medium term.

Tags: AIM market, Asia-Pacifuyc, Autopiclair, Chris Spooner, Dermatology, Wound care

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2014

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1,044 AIM-quoted companies. The full report is available to order for £365 + VAT. Click here for more info

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Oakley Capital previously took over legendary magazine group Time Out

Oakley grabs Damovo 30/01/2015

Private equity house Oakley Investments (AIM:OCL) has purchased IT group Damovo.

Herencia to sell La Serena 30/01/2015

Chilean miner Herencia Resources (AIM:HER) has agreed to sell the La Serena project in a deal worth $4 million (£2.65 million). 

Tags: Mining

SRT wins Malaysian contract 16/01/2015

Marine tracking specialist Software Radio Technology (AIM:SRT) has won a contract to supply its display system to a port in Malaysia.

Tags: South East Asia

Graphene still tough 16/01/2015

Materials company Graphene NanoChem (GRPH) issued a 'solid' update regarding its 2014 trading.

Cyan grabs Brazil win 18/12/2014

Smart metering outfit Cyan Holdings (AIM:CYAN) has won an order for 1,000 modules in Brazil.

Ideagen raises £17.5m and nabs Gael 18/12/2014

NHS Software specialist Ideagen (AIM:IDEA) is to acquire fellow software play Gael for £18 million.

More News